Skip to main content
Top
Published in: Journal of Clinical Immunology 2/2021

01-02-2021 | Primary Immunodeficiency | Original Article

Infection Phenotypes Among Patients with Primary Antibody Deficiency Mined from a US Patient Registry

Authors: Grant Pickett, Tina Motazedi, Carleigh Kutac, Gina Cahill, Charlotte Cunnigham-Rundles, Ramsay L. Fuleihan, Kathleen E. Sullivan, Nicholas L. Rider

Published in: Journal of Clinical Immunology | Issue 2/2021

Login to get access

Abstract

Purpose

Primary immunodeficiency disorders (PIDs) affect immune system development and/or function, increase infection susceptibility, and cause dysregulation or both. Recognition of PID requires assessment about the normal state of infection frequency and microbiology. To help clarify infection characteristics, we use data mined from the US Immunodeficiency Network (USIDNET) registry among primary antibody deficiency (PAD) patients before diagnosis.

Methods

We analyzed PAD patient data from the USIDNET registry prior to ultimate diagnosis. Our analysis included basic descriptive statistics for 8 major infection subtypes and significance testing for comparing infection rate by specific organisms across 7 distinct PAD subtypes.

Results

Of 2038 patients reviewed, 1259 (61.8%) had infections reported prior to diagnosis. Most (77.4%) had four or less reported infections prior to diagnosis; however, some suffered up to 16 infections. Infection patterns differed across the PAD subtypes. Patients with agammaglobulinemia differed significantly from patients with all other forms of PAD studied in at least one infection category, whereas patients with CVID differed from 3 other PAD categories in at least one infection category. Patterns of infections in patients with hypogammaglobulinemia, specific antibody deficiency, and transient hypogammaglobulinemia were less unique. For each of the infection types, bacteria were the most prevalent cause of disease.

Conclusions

Our data shows that distinct subtypes of PAD display unique infection patterns. We also show that patients with agammaglobulinemia suffer more invasive infections and differ most significantly from all other forms of PAD studied. Our analysis has broad implications about infection surveillance, progression, and vulnerability by PAD subtype.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tangye SG, al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40:24–64.CrossRef Tangye SG, al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40:24–64.CrossRef
2.
go back to reference McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy, Asthma Clin Immunol. 2018;14:61.CrossRef McCusker C, Upton J, Warrington R. Primary immunodeficiency. Allergy, Asthma Clin Immunol. 2018;14:61.CrossRef
4.
go back to reference Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312:729–38.CrossRef Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 2014;312:729–38.CrossRef
5.
go back to reference Rider NL, Miao D, Dodds M, Modell V, Modell F, Quinn J, et al. Calculation of a primary immunodeficiency “risk vital sign” via population-wide analysis of claims data to aid in clinical decision support. Front Pediatr. 2019;7:70.CrossRef Rider NL, Miao D, Dodds M, Modell V, Modell F, Quinn J, et al. Calculation of a primary immunodeficiency “risk vital sign” via population-wide analysis of claims data to aid in clinical decision support. Front Pediatr. 2019;7:70.CrossRef
6.
go back to reference Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61–70.CrossRef Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61–70.CrossRef
7.
go back to reference Boyle RJ, Le C, Balloch A, Tang ML. The clinical syndrome of specific antibody deficiency in children. Clin Exp Immunol. 2006;146:486–92.CrossRef Boyle RJ, Le C, Balloch A, Tang ML. The clinical syndrome of specific antibody deficiency in children. Clin Exp Immunol. 2006;146:486–92.CrossRef
8.
go back to reference Chun JK, Lee TJ, Song JW, Linton JA, Kim DS. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at severance hospital. Yonsei Med J. 2008;49:28–36.CrossRef Chun JK, Lee TJ, Song JW, Linton JA, Kim DS. Analysis of clinical presentations of Bruton disease: a review of 20 years of accumulated data from pediatric patients at severance hospital. Yonsei Med J. 2008;49:28–36.CrossRef
9.
go back to reference Cunningham-Rundles C, Knight AK. Common variable immune deficiency: reviews, continued puzzles, and a new registry. Immunol Res. 2007;38:78–86.CrossRef Cunningham-Rundles C, Knight AK. Common variable immune deficiency: reviews, continued puzzles, and a new registry. Immunol Res. 2007;38:78–86.CrossRef
10.
go back to reference Dominguez O, Giner MT, Alsina L, Martin MA, Lozano J, Plaza AM. Clinical phenotypes associated with selective IgA deficiency: a review of 330 cases and a proposed follow-up protocol. An Pediatr (Barc). 2012;76:261–7.CrossRef Dominguez O, Giner MT, Alsina L, Martin MA, Lozano J, Plaza AM. Clinical phenotypes associated with selective IgA deficiency: a review of 330 cases and a proposed follow-up protocol. An Pediatr (Barc). 2012;76:261–7.CrossRef
11.
go back to reference Kim JH, Park HJ, Choi GS, Kim JE, Ye YM, Nahm DH, et al. Immunoglobulin G subclass deficiency is the major phenotype of primary immunodeficiency in a Korean adult cohort. J Korean Med Sci. 2010;25:824–8.CrossRef Kim JH, Park HJ, Choi GS, Kim JE, Ye YM, Nahm DH, et al. Immunoglobulin G subclass deficiency is the major phenotype of primary immunodeficiency in a Korean adult cohort. J Korean Med Sci. 2010;25:824–8.CrossRef
12.
go back to reference Kutukculer N, Gulez N. The outcome of patients with unclassified hypogammaglobulinemia in early childhood. Pediatr Allergy Immunol. 2009;20:693–8.CrossRef Kutukculer N, Gulez N. The outcome of patients with unclassified hypogammaglobulinemia in early childhood. Pediatr Allergy Immunol. 2009;20:693–8.CrossRef
13.
go back to reference Pimenta F, Palma SMU, Constantino-Silva RN, Grumach AS. Hypogammaglobulinemia: a diagnosis that must not be overlooked. Braz J Med Biol Res. 2019;52:e8926.CrossRef Pimenta F, Palma SMU, Constantino-Silva RN, Grumach AS. Hypogammaglobulinemia: a diagnosis that must not be overlooked. Braz J Med Biol Res. 2019;52:e8926.CrossRef
14.
go back to reference Perez E, Bonilla FA, Orange JS, Ballow M. Specific antibody deficiency: controversies in diagnosis and management. Front Immunol. 2017;8:586.CrossRef Perez E, Bonilla FA, Orange JS, Ballow M. Specific antibody deficiency: controversies in diagnosis and management. Front Immunol. 2017;8:586.CrossRef
15.
go back to reference Nekooie-Marnany N, Deswarte C, Ostadi V, Bagherpour B, Taleby E, Ganjalikhani-Hakemi M, et al. Impaired IL-12- and IL-23-mediated immunity due to IL-12Rbeta1 deficiency in Iranian patients with Mendelian susceptibility to mycobacterial disease. J Clin Immunol. 2018;38:787–93.CrossRef Nekooie-Marnany N, Deswarte C, Ostadi V, Bagherpour B, Taleby E, Ganjalikhani-Hakemi M, et al. Impaired IL-12- and IL-23-mediated immunity due to IL-12Rbeta1 deficiency in Iranian patients with Mendelian susceptibility to mycobacterial disease. J Clin Immunol. 2018;38:787–93.CrossRef
16.
go back to reference Rosain J, Kong XF, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014-2018 update. Immunol Cell Biol. 2019;97:360–7.CrossRef Rosain J, Kong XF, Martinez-Barricarte R, Oleaga-Quintas C, Ramirez-Alejo N, Markle J, et al. Mendelian susceptibility to mycobacterial disease: 2014-2018 update. Immunol Cell Biol. 2019;97:360–7.CrossRef
17.
go back to reference Sarrafzadeh SA, Nourizadeh M, Mahloojirad M, Fazlollahi MR, Shokouhi Shoormasti R, Badalzadeh M, et al. Molecular, immunological, and clinical features of 16 Iranian patients with Mendelian susceptibility to mycobacterial disease. J Clin Immunol. 2019;39:287–97.CrossRef Sarrafzadeh SA, Nourizadeh M, Mahloojirad M, Fazlollahi MR, Shokouhi Shoormasti R, Badalzadeh M, et al. Molecular, immunological, and clinical features of 16 Iranian patients with Mendelian susceptibility to mycobacterial disease. J Clin Immunol. 2019;39:287–97.CrossRef
19.
go back to reference Sullivan KE, Puck JM, Notarangelo LD, Fuleihan R, Caulder T, Wang C, et al. USIDNET: a strategy to build a community of clinical immunologists. J Clin Immunol. 2014;34:428–35.CrossRef Sullivan KE, Puck JM, Notarangelo LD, Fuleihan R, Caulder T, Wang C, et al. USIDNET: a strategy to build a community of clinical immunologists. J Clin Immunol. 2014;34:428–35.CrossRef
20.
go back to reference Patrawala M, Cui Y, Peng L, Fuleihan RL, Garabedian EK, Patel K, et al. Pulmonary disease burden in primary immune deficiency disorders: data from USIDNET registry. J Clin Immunol. 2020;40:340–9.CrossRef Patrawala M, Cui Y, Peng L, Fuleihan RL, Garabedian EK, Patel K, et al. Pulmonary disease burden in primary immune deficiency disorders: data from USIDNET registry. J Clin Immunol. 2020;40:340–9.CrossRef
21.
go back to reference Michniacki TF, Connelly JA, Sturza J, Merz LE, Marsh R, Dale D, et al. Neutropenia is an underrecognized finding in pediatric primary immunodeficiency diseases: an analysis of the United States immunodeficiency network registry. J Pediatr Hematol Oncol. 2020;42:e601–5.CrossRef Michniacki TF, Connelly JA, Sturza J, Merz LE, Marsh R, Dale D, et al. Neutropenia is an underrecognized finding in pediatric primary immunodeficiency diseases: an analysis of the United States immunodeficiency network registry. J Pediatr Hematol Oncol. 2020;42:e601–5.CrossRef
22.
go back to reference Leung J, Sullivan KE, Perelygina L, Icenogle JP, Fuleihan RL, Lanzieri TM. Prevalence of granulomas in patients with primary immunodeficiency disorders, United States: data from national health care claims and the US immunodeficiency detwork registry. J Clin Immunol. 2018;38:717–26.CrossRef Leung J, Sullivan KE, Perelygina L, Icenogle JP, Fuleihan RL, Lanzieri TM. Prevalence of granulomas in patients with primary immunodeficiency disorders, United States: data from national health care claims and the US immunodeficiency detwork registry. J Clin Immunol. 2018;38:717–26.CrossRef
23.
go back to reference Mayor PC, Eng KH, Singel KL, Abrams SI, Odunsi K, Moysich KB, et al. Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry. J Allergy Clin Immunol. 2018;141:1028–35.CrossRef Mayor PC, Eng KH, Singel KL, Abrams SI, Odunsi K, Moysich KB, et al. Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry. J Allergy Clin Immunol. 2018;141:1028–35.CrossRef
24.
go back to reference Sadeghi B, Abolhassani H, Naseri A, Rezaei N, Aghamohammadi A. Economic burden of common variable immunodeficiency: annual cost of disease. Expert Rev Clin Immunol. 2015;11:681–8.CrossRef Sadeghi B, Abolhassani H, Naseri A, Rezaei N, Aghamohammadi A. Economic burden of common variable immunodeficiency: annual cost of disease. Expert Rev Clin Immunol. 2015;11:681–8.CrossRef
25.
go back to reference Odnoletkova I, et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J Rare Dis. 2018;13:201.CrossRef Odnoletkova I, et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J Rare Dis. 2018;13:201.CrossRef
26.
go back to reference Holding S, Khan S, Sewell WA, Jolles S, Dore PC. Using calculated globulin fraction to reduce diagnostic delay in primary and secondary hypogammaglobulinaemias: results of a demonstration project. Ann Clin Biochem. 2015;52:319–26.CrossRef Holding S, Khan S, Sewell WA, Jolles S, Dore PC. Using calculated globulin fraction to reduce diagnostic delay in primary and secondary hypogammaglobulinaemias: results of a demonstration project. Ann Clin Biochem. 2015;52:319–26.CrossRef
27.
go back to reference Hartono S, Ippoliti MR, Mastroianni M, Torres R, Rider NL. Gastrointestinal disorders associated with primary immunodeficiency diseases. Clin Rev Allergy Immunol. 2019;57:145–65.CrossRef Hartono S, Ippoliti MR, Mastroianni M, Torres R, Rider NL. Gastrointestinal disorders associated with primary immunodeficiency diseases. Clin Rev Allergy Immunol. 2019;57:145–65.CrossRef
28.
go back to reference Rider NL, Kutac C, Hajjar J, Scalchunes C, Seeborg FO, Boyle M, et al. Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment. J Clin Immunol. 2017;37:461–75.CrossRef Rider NL, Kutac C, Hajjar J, Scalchunes C, Seeborg FO, Boyle M, et al. Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment. J Clin Immunol. 2017;37:461–75.CrossRef
29.
go back to reference Seeborg FO, Seay R, Boyle M, Boyle J, Scalchunes C, Orange JS. Perceived health in patients with primary immune deficiency. J Clin Immunol. 2015;35:638–50.CrossRef Seeborg FO, Seay R, Boyle M, Boyle J, Scalchunes C, Orange JS. Perceived health in patients with primary immune deficiency. J Clin Immunol. 2015;35:638–50.CrossRef
30.
go back to reference Hajjar J, Guffey D, Minard CG, Orange JS. Increased incidence of fatigue in patients with primary immunodeficiency disorders: prevalence and associations within the US immunodeficiency network registry. J Clin Immunol. 2017;37:153–65.CrossRef Hajjar J, Guffey D, Minard CG, Orange JS. Increased incidence of fatigue in patients with primary immunodeficiency disorders: prevalence and associations within the US immunodeficiency network registry. J Clin Immunol. 2017;37:153–65.CrossRef
31.
go back to reference Mortaz E, Azempour E, Mansouri D, Tabarsi P, Ghazi M, Koenderman L, et al. Common infections and target organs associated with chronic granulomatous disease in Iran. Int Arch Allergy Immunol. 2019;179:62–73.CrossRef Mortaz E, Azempour E, Mansouri D, Tabarsi P, Ghazi M, Koenderman L, et al. Common infections and target organs associated with chronic granulomatous disease in Iran. Int Arch Allergy Immunol. 2019;179:62–73.CrossRef
32.
go back to reference Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H, et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood. 2011;117:53–62.CrossRef Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H, et al. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood. 2011;117:53–62.CrossRef
33.
go back to reference Tirosh O, et al. Expanded skin virome in DOCK8-deficient patients. Nat Med. 2018;24:1815–21.CrossRef Tirosh O, et al. Expanded skin virome in DOCK8-deficient patients. Nat Med. 2018;24:1815–21.CrossRef
34.
go back to reference Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, et al. The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1. J Clin Immunol. 2016;36:73–84.CrossRef Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, et al. The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1. J Clin Immunol. 2016;36:73–84.CrossRef
35.
go back to reference Cilloniz C, Martin-Loeches I, Garcia-Vidal C, San Jose A, Torres A. Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns. Int J Mol Sci. 2016;17(12):2120. Cilloniz C, Martin-Loeches I, Garcia-Vidal C, San Jose A, Torres A. Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns. Int J Mol Sci. 2016;17(12):2120.
36.
go back to reference Vergison A. Microbiology of otitis media: a moving target. Vaccine. 2008;26:G5–10.CrossRef Vergison A. Microbiology of otitis media: a moving target. Vaccine. 2008;26:G5–10.CrossRef
37.
go back to reference Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328:21–8.CrossRef Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993;328:21–8.CrossRef
38.
go back to reference Bonilla FA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186–205 e1–78.CrossRef Bonilla FA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136:1186–205 e1–78.CrossRef
Metadata
Title
Infection Phenotypes Among Patients with Primary Antibody Deficiency Mined from a US Patient Registry
Authors
Grant Pickett
Tina Motazedi
Carleigh Kutac
Gina Cahill
Charlotte Cunnigham-Rundles
Ramsay L. Fuleihan
Kathleen E. Sullivan
Nicholas L. Rider
Publication date
01-02-2021
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2021
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-020-00916-1

Other articles of this Issue 2/2021

Journal of Clinical Immunology 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine